Atlantic Coastal Acquisition Corp. II (ACABW) Competitors $0.05 +0.00 (+2.93%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ACABW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, BFRIW, BTMDW, BCTXW, CALA, and CELUWShould you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Atlantic Coastal Acquisition Corp. II vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Biofrontera biote BriaCell Therapeutics Calithera Biosciences Celularity 180 Life Sciences (NASDAQ:ATNFW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability. Is ATNFW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Which has stronger earnings & valuation, ATNFW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Does the media favor ATNFW or ACABW? In the previous week, 180 Life Sciences had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for Atlantic Coastal Acquisition Corp. II. 180 Life Sciences' average media sentiment score of 0.48 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Neutral Atlantic Coastal Acquisition Corp. II Neutral Summary180 Life Sciences beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks. Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACABW vs. The Competition Export to ExcelMetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$479.31M$6.31B$9.52BDividend YieldN/A5.35%4.19%4.09%P/E RatioN/A0.7814.0423.81Price / SalesN/A583.871,848.5266.04Price / CashN/A178.73127.5357.96Price / BookN/A3.182.245.54Net IncomeN/A-$141.08M$1.23B$259.28M7 Day PerformanceN/A0.86%6.06%-4.64%1 Month PerformanceN/A2.91%1.81%4.41%1 Year PerformanceN/A27.87%19.31%17.95% Atlantic Coastal Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05+2.9%N/A-35.3%$0.00N/A0.0015ATNFW180 Life SciencesN/A$0.01+17.3%N/A+18.6%$0.00N/A0.007News CoverageGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.14-15.7%N/AN/A$0.00$106.21K0.0040Gap UpALVOWAlvotechN/A$1.93-1.0%N/A-47.5%$0.00$585.60M0.004Gap DownBFRIWBiofronteraN/A$0.10flatN/A+400.0%$0.00$38.00M0.0070Positive NewsGap DownBTMDWbioteN/A$0.01-4.7%N/A-97.2%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.04-27.5%N/A-82.0%$0.00N/A0.008Positive NewsShort Interest ↑Gap UpCALACalithera BiosciencesN/A$0.00flatN/AN/A$0.00N/A0.0060CELUWCelularityN/A$0.04-6.9%N/AN/A$0.00$54.22M0.00220News CoveragePositive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Calithera Biosciences Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACABW) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACABW Stock Alerts